Royal Bank of Canada’s Monte Rosa Therapeutics GLUE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.12M | Buy |
469,798
+466,647
| +14,809% | +$2.1M | ﹤0.01% | 2974 |
|
|
2025
Q1 | $14K | Sell |
3,151
-2,452
| -44% | -$10.9K | ﹤0.01% | 5658 |
|
|
2024
Q4 | $39K | Buy |
5,603
+1,138
| +25% | +$7.92K | ﹤0.01% | 5316 |
|
|
2024
Q3 | $23K | Buy |
4,465
+278
| +7% | +$1.43K | ﹤0.01% | 5583 |
|
|
2024
Q2 | $16K | Buy |
4,187
+2,985
| +248% | +$11.4K | ﹤0.01% | 5765 |
|
|
2024
Q1 | $9K | Sell |
1,202
-9,916
| -89% | -$74.2K | ﹤0.01% | 5787 |
|
|
2023
Q4 | $63K | Buy |
11,118
+3,719
| +50% | +$21.1K | ﹤0.01% | 5352 |
|
|
2023
Q3 | $36K | Buy |
7,399
+3,711
| +101% | +$18.1K | ﹤0.01% | 5453 |
|
|
2023
Q2 | $25K | Buy |
3,688
+1,503
| +69% | +$10.2K | ﹤0.01% | 5632 |
|
|
2023
Q1 | $17K | Sell |
2,185
-3,030
| -58% | -$23.6K | ﹤0.01% | 5695 |
|
|
2022
Q4 | $39K | Buy |
5,215
+4,366
| +514% | +$32.7K | ﹤0.01% | 5556 |
|
|
2022
Q3 | $7K | Buy |
849
+187
| +28% | +$1.54K | ﹤0.01% | 6098 |
|
|
2022
Q2 | $7K | Sell |
662
-1,613
| -71% | -$17.1K | ﹤0.01% | 6052 |
|
|
2022
Q1 | $32K | Sell |
2,275
-1,080
| -32% | -$15.2K | ﹤0.01% | 5861 |
|
|
2021
Q4 | $68K | Buy |
3,355
+2,076
| +162% | +$42.1K | ﹤0.01% | 5663 |
|
|
2021
Q3 | $29K | Buy |
+1,279
| New | +$29K | ﹤0.01% | 5960 |
|